Recently in Pharmaceuticals Category

November 22, 2011

Second-Generation Antipsychotic Drugs May Increase Risk of Diabetes in Children (11.22.11)

Recent data indicate that children taking second-generation antipsychotic medications experience a higher incidence of diabetes. Further studies are needed to firmly establish this link. Antipsychotic Medication Use Among Children and Risk of Diabetes Mellitus

May 10, 2011

Non-Steroidal Anti-Inflammatory (NSAID) Drugs Harmful For Heart Disease Patients (5.10.11)

The American Heart Association in 2005 reported that NSAIDs increased the risk of myocardial infarct (heart attack) in patients who had heart disease or had suffered an MI. Since that time additional studies have reaffirmed and strengthened these findings. In fact, it is now considered unsafe to prescribe NSAIDs for even a short period to patients who have suffered an MI or have heart disease. Just one week of NSAIDs can increase the risk of an MI by 45%.

Use of Nonsteroidal Antiinflammatory Drugs

February 8, 2011

New Anticoagulant Dabigatran Degrades 30 Days After Opening Bottle (2.8.11)

After opening a bottle of Dabigatran it begins to degrade quickly due to humidity in the air. Despite a desiccant (drying agent) built into the bottle cap, the drug will lose its effectiveness 30 days after opening. Use Dabigatran Within 30 Days of Opening

January 21, 2011

New Drug Effective in Treating Metastic Melonoma (1.21.11)

Study data show that RG7204 stabilizes or reduces melanoma tumor size by over 80%. The drug may be available on the market by as early as 2012.
RG7204, a BRAF Inhibitor, Demonstrates Promising Results in Metastatic Melanoma

January 21, 2011

Febrile (Fever) Seizures Occurring in Some Infants Receiving Fluzone (trivalent inactivated influenza vaccine) (1.21.11)

Although still considered safe, Fluzone has recently been associated with febrile seizures in some infants receiving the vaccination. To report an incident with this or any other vaccine, go to: The Vaccine Adverse Event Reporting System (VAERS)

Fluzone considered safe for children despite increased reports in VAERS of febrile seizures

January 13, 2011

Women Exposed to Benzodiazepines During Reproductive Years Have Increased Risk of Oral Cleft in Newborns (1.13.11)

Updated data from various studies show that women of reproductive age exposed to Benzodiazepines have a twofold increased risk of having children with oral cleft.

DRUGS IN PREGNANCY

November 19, 2010

Propoxyphene (Darvon/Darvocet) Removed from Market Due to Risk of Serious Cardiac Toxicity

Xanodyne Pharmaceuticals will remove propoxyphene from the U.S. market due to serious toxicity to the heart.
For further information, go to: Propoxyphene: Withdrawal - Risk of Cardiac Toxicity

October 29, 2010

Heparin Recalled Due to Trace Contaminant (10.29.10)

Various lots of Heparin sold by B. Braun Medical Inc., manufactured in2008, have been recalled because of a trace amount of oversulfated chondroitin sulfate (OSCS) contaminant.
To file a report regarding adverse reactions to this Heparin:
• Complete and submit the report Online: www.fda.gov/MedWatch/report.htm
Download form or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178
For further information, go to: Heparin Sodium (B. Braun): Recall - Trace Contaminant

July 2, 2010

Rosiglitazone: More Evidence Showing Adverse Cardiovascular Events (7.2.10)

For over a decade thiazolidinediones (TZDs) have been used for glycemic control for diabetic patients. During that time studies and clinical findings demonstrated that TZDs resulted in adverse cardiovascular events. Now additional studies point to increased risks of stroke, AMI (acute myocardial infarct), heart failure and death.
It is hoped that in light of these findings the FDA will reconsider the continued marketing of rosiglitazone.

More Bad News for Rosiglitazone

June 16, 2010

Statins Associated with Liver Dysfunction, Acute Renal Failure, Myopathy and Cataracts (6.16.10)

Data from the University of Nottingham show that some statins increase the risk of liver dysfunction, acute renal failue, myopathy and cataracts. The study involved more than two million patients between 30-84 years' old from 2002 to 2008. Physicians are now encouraged to closely monitor their patients who are taking statins.

See the study at: Unintended effects of statins in men and women in England and Wales: population based cohort study using the QResearch database

See the accompanying editorial at: Balancing the intended and unintended effects of statins

Companion paper in the journal Heart: Individualising the risks of statins in men and women in England and Wales: population-based cohort study

Some Statins Have Unintended Effects and Warrant Closer Monitoring, Study Finds


June 7, 2010

Prescription Drugs Printed on Pill Offer Safer, More Effective Treatment (6.7.10)

Most prescriptions are offered in tablet form today. Tablets unfortunately are made of more than 99% fillers. The actual prescription medication is less than 1% of the pill and is mixed in with the fillers. This requires digesting the entire pill before the medication is in your system.

Fortunately, the University of Leeds and Durham University are attempting to develop a process where prescriptions can be imprinted on the exterior of tablets. A process that GlaxoSmithKline developed but can only use in less than 1% of prescriptions.

The benefits of printable prescriptions will be faster acting and will allow for printing several prescriptions onto one pill.

For additional information, go to: Printable prescription pills will be safer and faster-acting

June 7, 2010

Off-Label Use of Drugs Draws Large Fines But Doesn't Deter Drug Manufacturers (6.7.10)

In spite of recent significant off-label-use fines, Pfizer and Johnson & Johnson continue to condone off-label uses of their drugs to increase their overall profit.

For additional information, go to: Drugmakers continue 'off-label marketing' despite large fines